Kazuko Matsuda

Summary

Publications

  1. doi request reprint Evaluation of bedoradrine sulfate (MN-221), a novel, highly selective beta2-adrenergic receptor agonist for the treatment of asthma via intravenous infusion
    Kazuko Matsuda
    MediciNova, Inc, San Diego, CA 92122, USA
    J Asthma 49:1071-8. 2012

Detail Information

Publications1

  1. doi request reprint Evaluation of bedoradrine sulfate (MN-221), a novel, highly selective beta2-adrenergic receptor agonist for the treatment of asthma via intravenous infusion
    Kazuko Matsuda
    MediciNova, Inc, San Diego, CA 92122, USA
    J Asthma 49:1071-8. 2012
    ..MN-221 (bedoradrine sulfate) is a novel, highly selective beta2- (β2-) adrenergic agonist administered via intravenous (IV) infusion in development for the treatment for acute exacerbation of asthma...